The landscape of dementia diagnosis has progressed drastically with the appearance of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-centered tests that may detect Alzheimer's pathology several years in advance of indications arise. While these technological developments symbolize impressive development in knowledge ne